UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 8.

Brookman-May, S; May, M; Zigeuner, R; Shariat, S F; Scherr, D S; Chromecki, T; Moch, H; Wild, P J; Mohamad-Al-Ali, B; Cindolo, L; Wieland, W F; Schips, L; De Cobelli, O; Rocco, B; Santoro, L; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Hohenfellner, M; Gilfrich, C; Wirth, M P; Burger, M; Pahernik, S (2011). Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. Journal of Urology, 186(6):2175-2181.

Mugavero, M J; May, M; Ribaudo, H J; Gulick, R M; Riddler, S A; Haubrich, R; Napravnik, S; Abgrall, S; Phillips, A; Harris, R; Gill, M J; de Wolf, F; Hogg, R; Günthard, H F; Chêne, G; D'Arminio Monforte, A; Guest, J L; Smith, C; Murillas, J; Berenguer, J; Wyen, C; Domingo, P; Kitahata, M M; Sterne, J A C; Saag, M S (2011). Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study. Journal of Acquired Immune Deficiency Syndromes, 58(3):253-260.

May, M; Brookman-Amissah, S; Roigas, J; Hartmann, A; Störkel, S; Kristiansen, G; Gilfrich, C; Borchardt, R; Hoschke, B; Kaufmann, O; Gunia, S (2010). Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. European Urology, 57(5):850-858.

Zwahlen, M; Harris, R; May, M; Hogg, R; Costagliola, D; de Wolf, F; Gill, J; Fätkenheuer, G; Lewden, C; Saag, M; Staszewski, S; D'Arminio Monforte, A; Casabona, J; Lampe, F; Justice, A; von Wyl, V; Egger, M (2009). Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. International Journal of Epidemiology, 38(6):1624-1633.

Sterne, J A C; May, M; Costagliola, D; de Wolf, F; Phillips, A N; Harris, R; Funk, M J; Geskus, R B; Gill, J; Dabis, F; Miró, J M; Justice, A C; Ledergerber, B; Fätkenheuer, G; Hogg, R S; Monforte, A D; Saag, M; Smith, C; Staszewski, Sc; Egger, M; Cole, S R (2009). Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet, 373(9672):1352-1363.

Mugavero, M J; May, M; Harris, R; Saag, M S; Costagliola, D; Egger, M; Phillips, A; Günthard, H F; Dabis, F; Hogg, R; de Wolf, F; Fatkenheuer, G; Gill, M J; Justice, A; D'Arminio Monforte, A; Lampe, F; Miró, J M; Staszewski, S; Sterne, J A C (2008). Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? AIDS, 22(18):2481-2492.

Gunia, S; May, M; Scholmann, K; Störkel, S; Hoschke, B; Koch, S; Dietel, M; Kristiansen, G (2008). Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Archiv, 453(2):165-170.

Weber, A; Kristiansen, I; Johannsen, M; Oelrich, B; Scholmann, K; Gunia, S; May, M; Meyer, H A; Behnke, S; Moch, H; Kristiansen, G (2008). The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer, 8:369:1-11.

This list was generated on Fri Jul 21 00:33:58 2017 CEST.